Y. Lai, L. J. Huang, Hsien‐Cheng Lin, Tian-Shung Wu, C. Teng, S. Kuo
{"title":"强效抗血小板药物姜二酮衍生物的合成","authors":"Y. Lai, L. J. Huang, Hsien‐Cheng Lin, Tian-Shung Wu, C. Teng, S. Kuo","doi":"10.7019/CPJ.200208.0259","DOIUrl":null,"url":null,"abstract":"In search of novel antiplatelet agents, the naturally-occurring gingerdiones (20, 24) were selected as lead com pounds. A series of their derivatives were synthesized and screened for anti-platelet activity. It was found that all of the synthesized gingerdione derivatives demonstrated potent inhibition against AA-induced platelet aggregation. Among them, 141-gingerdione (I8) and 51-gingerdione (19) showed the highest potency, being about 1/3 and one time as potent as indomethacin, respectively. Preliminary studies indicated that the mechanism of action of these gingerdione derivatives differed from indomethacin. Unlike indomethacin, they showed no appreciable COX-I and COX-2 inhibition. The exact mechanism of action of these new compounds","PeriodicalId":22409,"journal":{"name":"The Chinese Pharmaceutical Journal","volume":"55 1","pages":"259-269"},"PeriodicalIF":0.0000,"publicationDate":"2002-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Synthesis of Gingerdione Derivatives as Potent Antiplatelet Agents\",\"authors\":\"Y. Lai, L. J. Huang, Hsien‐Cheng Lin, Tian-Shung Wu, C. Teng, S. Kuo\",\"doi\":\"10.7019/CPJ.200208.0259\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In search of novel antiplatelet agents, the naturally-occurring gingerdiones (20, 24) were selected as lead com pounds. A series of their derivatives were synthesized and screened for anti-platelet activity. It was found that all of the synthesized gingerdione derivatives demonstrated potent inhibition against AA-induced platelet aggregation. Among them, 141-gingerdione (I8) and 51-gingerdione (19) showed the highest potency, being about 1/3 and one time as potent as indomethacin, respectively. Preliminary studies indicated that the mechanism of action of these gingerdione derivatives differed from indomethacin. Unlike indomethacin, they showed no appreciable COX-I and COX-2 inhibition. The exact mechanism of action of these new compounds\",\"PeriodicalId\":22409,\"journal\":{\"name\":\"The Chinese Pharmaceutical Journal\",\"volume\":\"55 1\",\"pages\":\"259-269\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Chinese Pharmaceutical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7019/CPJ.200208.0259\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Chinese Pharmaceutical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7019/CPJ.200208.0259","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Synthesis of Gingerdione Derivatives as Potent Antiplatelet Agents
In search of novel antiplatelet agents, the naturally-occurring gingerdiones (20, 24) were selected as lead com pounds. A series of their derivatives were synthesized and screened for anti-platelet activity. It was found that all of the synthesized gingerdione derivatives demonstrated potent inhibition against AA-induced platelet aggregation. Among them, 141-gingerdione (I8) and 51-gingerdione (19) showed the highest potency, being about 1/3 and one time as potent as indomethacin, respectively. Preliminary studies indicated that the mechanism of action of these gingerdione derivatives differed from indomethacin. Unlike indomethacin, they showed no appreciable COX-I and COX-2 inhibition. The exact mechanism of action of these new compounds